66 related articles for article (PubMed ID: 21382154)
1. Prognostic potential of hepatic miR-122 measurements and antisense strategies targeting miR-122 as a therapeutic approach in viral hepatitis.
Filipowicz M
Liver Int; 2011 Apr; 31(4):437-9. PubMed ID: 21382154
[No Abstract] [Full Text] [Related]
2. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
Esau C; Davis S; Murray SF; Yu XX; Pandey SK; Pear M; Watts L; Booten SL; Graham M; McKay R; Subramaniam A; Propp S; Lollo BA; Freier S; Bennett CF; Bhanot S; Monia BP
Cell Metab; 2006 Feb; 3(2):87-98. PubMed ID: 16459310
[TBL] [Abstract][Full Text] [Related]
3. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.
Young DD; Connelly CM; Grohmann C; Deiters A
J Am Chem Soc; 2010 Jun; 132(23):7976-81. PubMed ID: 20527935
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
5. The liver-specific microRNA miR-122: biology and therapeutic potential.
Filipowicz W; Grosshans H
Prog Drug Res; 2011; 67():221-38. PubMed ID: 21141732
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C.
Morita K; Taketomi A; Shirabe K; Umeda K; Kayashima H; Ninomiya M; Uchiyama H; Soejima Y; Maehara Y
Liver Int; 2011 Apr; 31(4):474-84. PubMed ID: 21199296
[TBL] [Abstract][Full Text] [Related]
7. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
Jopling CL; Yi M; Lancaster AM; Lemon SM; Sarnow P
Science; 2005 Sep; 309(5740):1577-81. PubMed ID: 16141076
[TBL] [Abstract][Full Text] [Related]
8. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis.
Zhang H; Cook J; Nickel J; Yu R; Stecker K; Myers K; Dean NM
Nat Biotechnol; 2000 Aug; 18(8):862-7. PubMed ID: 10932156
[TBL] [Abstract][Full Text] [Related]
9. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Jopling CL; Norman KL; Sarnow P
Cold Spring Harb Symp Quant Biol; 2006; 71():369-76. PubMed ID: 17381319
[TBL] [Abstract][Full Text] [Related]
10. No miR hype: microRNA's cancer role expands.
Garber K
J Natl Cancer Inst; 2006 Jul; 98(13):885-7. PubMed ID: 16818850
[No Abstract] [Full Text] [Related]
11. Efficient in vivo microRNA targeting of liver metastasis.
Huynh C; Segura MF; Gaziel-Sovran A; Menendez S; Darvishian F; Chiriboga L; Levin B; Meruelo D; Osman I; Zavadil J; Marcusson EG; Hernando E
Oncogene; 2011 Mar; 30(12):1481-8. PubMed ID: 21102518
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.
Ji R; Cheng Y; Yue J; Yang J; Liu X; Chen H; Dean DB; Zhang C
Circ Res; 2007 Jun; 100(11):1579-88. PubMed ID: 17478730
[TBL] [Abstract][Full Text] [Related]
13. Regulation and biological function of the liver-specific miR-122.
Lewis AP; Jopling CL
Biochem Soc Trans; 2010 Dec; 38(6):1553-7. PubMed ID: 21118125
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
Moriya K; Matsukura M; Kurokawa K; Koike K
Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
[TBL] [Abstract][Full Text] [Related]
15. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression.
Rouas R; Fayyad-Kazan H; El Zein N; Lewalle P; Rothé F; Simion A; Akl H; Mourtada M; El Rifai M; Burny A; Romero P; Martiat P; Badran B
Eur J Immunol; 2009 Jun; 39(6):1608-18. PubMed ID: 19408243
[TBL] [Abstract][Full Text] [Related]
16. RNA interference--small RNAs effectively fight viral hepatitis.
Shlomai A; Shaul Y
Liver Int; 2004 Dec; 24(6):526-31. PubMed ID: 15566500
[TBL] [Abstract][Full Text] [Related]
17. Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.
Toulmé JJ; Bourget C; Compagno D; Yurchenko L
Parasitology; 1997; 114 Suppl():S45-59. PubMed ID: 9309768
[TBL] [Abstract][Full Text] [Related]
18. Construction and identification of a human liver specific microRNA eukaryotic expression vector.
Chen S; Ni M; Yu B; Lv T; Lu M; Gong F
Cell Mol Immunol; 2007 Dec; 4(6):473-7. PubMed ID: 18163960
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
Matsubara H; Takeuchi T; Nishikawa E; Yanagisawa K; Hayashita Y; Ebi H; Yamada H; Suzuki M; Nagino M; Nimura Y; Osada H; Takahashi T
Oncogene; 2007 Sep; 26(41):6099-105. PubMed ID: 17384677
[TBL] [Abstract][Full Text] [Related]
20. [Up-regulation of p27(kip1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma].
Zhang C; Wang G; Kang C; Du Y; Pu P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):634-8. PubMed ID: 19953484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
